Home » Topics » Disease categories and therapies » Urology

Urology
RSS

Nymox reports results from U.S. NX-1207 study in benign prostatic hyperplasia

March 13, 2008

Genzyme launches Renvela in the U.S. for dialysis patients and submits MAA to the EMEA

March 7, 2008

New agents for treating urolithiasis disclosed in recent University of Western Ontario patent

March 7, 2008

New beta3 adrenoceptor agonists may be useful in overactive bladder

March 5, 2008

Biogen Idec and Cardiokine initiate a phase III study of lixivaptan

Feb. 18, 2008

New therapeutic agents for urinary incontinence imparted in recent Takeda patents

Feb. 18, 2008

Silodosin NDA accepted for filing by FDA for benign prostatic hyperplasia

Feb. 13, 2008

Plethora reports preliminary results from PSD-506 incontinence study

Feb. 8, 2008

Positive results reported from Nymox's U.S. study of NX-1207 for BPH

Feb. 7, 2008

New therapeutic agents for genitourinary disorders reported in recent Roche patent

Feb. 5, 2008

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 29, 2026.
TROP2 ADCs progress into first-line for lung, breast cancers
BioWorld
Multiple updates on TROP2-directed antibody-drug conjugates (ADCs) for lung and breast cancers highlight both progress made and opportunities for improvement for...
New evidence links autoimmunity to long COVID symptoms
BioWorld
Recent findings are reshaping current understanding of the post-infection landscape of SARS-CoV-2. Although previous studies had already suggested that...
Will Ovid’s golden age of KCC2 metamorph CNS?
BioWorld
The “deep dive” April 8 by Ovid Therapeutics Inc. into potassium-chloride co-transporter 2 (KCC2) research included company officials and independent experts in...
Breakthrough as GSK’s bepirovirsen clears 19% of chronic hep B infections
BioWorld
GSK plc has announced a breakthrough in the treatment of chronic hepatitis B, reporting a functional cure rate of 19% across two phase III trials of its antisense...